InvestorsHub Logo
Followers 14
Posts 818
Boards Moderated 1
Alias Born 11/13/2019

Re: None

Friday, 07/28/2023 8:38:04 AM

Friday, July 28, 2023 8:38:04 AM

Post# of 111
$OKYO - Plans to Initiate Phase 2 Trial of OK-101 in Neuropathic Corneal Pain Following Announcement of Clinical Trial Agreement with Tufts Medical Center
👆Up 6.3% Pre-Market/ Current Price $2.05
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent OKYO News